Companies in the News

3.25.2020

San Francisco-based Vir Biotechnology indicated it has identified several human monoclonal antibody (mAb) candidates against SARS-CoV-2, the virus causing COVID-19. In the interest of saving time, the company’s lead development was transferred to WuXi Biologics and Biogen several weeks ago with human tria...

3.18.2020

  • Research Collaboration to Develop Next Generation Cell-based Therapies for Solid Tumors

  • $40 Million Raised by CERo to Facilitate Preclinical and Clinical Development

South San Francisco, Calif. – March 18, 2020 – CERo Therapeutics, Inc., a privately held biopharmaceutical company, today announc...

3.18.2020

-- Research Collaboration to Develop Next Generation Cell-based Therapies for Solid Tumors --

-- $40 Million Raised by CERo to Facilitate Preclinical and Clinical Development --

SOUTH SAN FRANCISCO, Calif., March 18, 2020 (GLOBE NEWSWIRE) -- CERo Therapeutics, Inc., a privately held biopharmaceutical compan...

Please reload